ArticleFrontiers in pediatrics2026
Retinopathy of prematurity remains the leading cause of childhood blindness in children attending schools for the blind in Guadalajara: a fifteen-year comparison.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify the main causes of blindness in children attending at 3 schools for blind in the metropolitan area of Guadalajara (MAG), Jalisco, Mexico and to highlight the importance of preventing childhood visual disability. Methods: An observational, cross-sectional, and descriptive study was conducted in students enrolled in three schools for children with visual disabilities during the period September-December 2025 in Guadalajara, Jalisco, Mexico. Information was obtained from the review of clinical and school records, interviews with parents, and ophthalmologic evaluation, with prior institutional approval from the participating schools. A standardized World Health Organization (WHO) form was used to record sociodemographic variables, perinatal history, ophthalmologic diagnosis, etiology, treatments, and comorbidities. A descriptive analysis with an epidemiological approach was carried out using frequencies and measures of central tendency. Finally, the information was anonymized and handled confidentially, in accordance with ethical research principles. Results: This school-based, observational, descriptive cross-sectional study included a total of 106 children, 55 were female (51%) and 51 were male (49%). Retinal disorders constituted the main cause of visual loss with 64 cases (60%), predominantly sequelae of retinopathy of prematurity (ROP) in 50 children (47%). The second cause identified was optic nerve abnormalities with 19 cases (18%). 57 cases (54%) were associated with factors from the neonatal period. 50 children (47%) with diagnosis of ROP, had a mean gestational age of 30.6 weeks and a mean birth weight of 1443 g; 8 children (16%) were outside Mexican screening criteria and 28 (56%) outside United Kingdom criteria. 44 children (88%) with ROP presented blindness and 34 (68%) did not receive treatment and neurodevelopmental comorbidities were identified in 7 children (14%). Conclusions: Childhood blindness in the studied population was predominantly associated with potentially preventable causes, especially sequelae of ROP, positioning itself as the leading cause of childhood blindness in a school-based sample in Guadalajara. It is necessary to strengthen the prevention of retinopathy of prematurity through neonatal care, ensuring timely detection and treatment, as well as adapting neonatal screening programs and criteria to the regional context to reduce the burden of childhood visual impairment. These findings highlight the persistence of preventable ROP-related blindness among children attending specialized schools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.